Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hidden diabetes risk in hepatitis c kids?

NCT ID NCT07238530

Knowledge-focused Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study checked whether children with hepatitis C who also have thalassemia or survived childhood cancer are more likely to develop insulin resistance (a step toward diabetes). Researchers compared 90 infected children to healthy kids of the same age and gender. They measured blood sugar, insulin, and liver function, but did not give any treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

90 people

The number who actually took part.

Started

Sep 2015

Finished

Jul 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient group: Hepatitis C infected children and adolescents who are either thalassemia patients or survivors of childhood malignancy. Control group: Age and sex matched healthy children and adolescents who are following up at pediatric outpatient clinic

Ages

3 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * hepatitis C virus ribonucleic acid (RNA) positive children, who were following up at the pediatric hematology and oncology clinic Exclusion Criteria: * patients with concurrent active hepatitis B virus infection (positive for hepatitis B surface antigen) or * autoimmune hepatitis, * primary biliary cirrhosis (PBC), * sclerosing cholangitis, * haemochromatosis, * α1-antitrypsin deficiency, * Wilson's disease, * patients with obesity (BMI \> 25), or * Type 2 DM.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Childhood malignancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm hepatitis C virus infection thalassemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

This study is to assess occurence of insulin resistance among hepatits C infected children whether thalassemic or survivors of childhood malignancy

Contacts and locations

Locations

  • Pediatric hematology and Oncology clinic, Children's Hospital, Ain Shams university

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.